cbdMD backs White House call for fair federal treatment of hemp-derived products

cbdMD, Inc.

cbdMD, Inc.

YCBD

0.00
  • cbdMD backed a White House call urging Congress to revise federal hemp rules to ensure fair treatment of hemp-derived products.
  • The Administration request seeks to preserve access to full-spectrum CBD products while maintaining restrictions on products that pose health risks.
  • It also urged adoption of a federal framework or an extension of the current implementation timeline to give lawmakers more time.
  • cbdMD highlighted its NYSE American listing as U.S. exchanges begin allowing listings for compliant “plant-touching” medical cannabis operators.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606251413PR_NEWS_USPR_____CL92640) on June 25, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.